Trials / Terminated
TerminatedNCT04159935
Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- University of Waterloo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical trial is to investigate the efficacy of a single iLux® treatment in symptomatic CL wearers who have DED (according to the TFOS DEWS II diagnostic criteria), of the evaporative dry eye disease subtype (EDE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iLux® system | Commercially available medical device intended for use by qualified eye care professionals to apply localized heat and pressure therapy to a patient's eyelids. |
Timeline
- Start date
- 2019-11-15
- Primary completion
- 2020-04-14
- Completion
- 2020-04-14
- First posted
- 2019-11-12
- Last updated
- 2023-05-16
- Results posted
- 2023-05-16
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04159935. Inclusion in this directory is not an endorsement.